Fig. 10From: Distinguishing IDH mutation status in gliomas using FTIR-ATR spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregationMean values for each group in the second derivative spectrum of plasma. IDH-mutant glioma group (30 patients), IDH wild-type glioma group (54 patients), and healthy control group (72 persons)Back to article page